OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cardio-renal protection in older people with diabetes with frailty and medical comorbidities - A focus on the new hypoglycaemic therapy
Ahmed H. Abdelhafiz, Alan J. Sinclair
Journal of Diabetes and its Complications (2020) Vol. 34, Iss. 9, pp. 107639-107639
Closed Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Treatment of chronic kidney disease in older populations
Seiji Kishi, Hiroyuki Kadoya, Naoki Kashihara
Nature Reviews Nephrology (2024) Vol. 20, Iss. 9, pp. 586-602
Closed Access | Times Cited: 17

Comparative Cardiovascular Effectiveness and Safety of SGLT-2 Inhibitors, GLP-1 Receptor Agonists, and DPP-4 Inhibitors According to Frailty in Type 2 Diabetes
Alexander Kutz, Dae Hyun Kim, Deborah J. Wexler, et al.
Diabetes Care (2023) Vol. 46, Iss. 11, pp. 2004-2014
Open Access | Times Cited: 41

Functional and Clinical Importance of SGLT2-inhibitors in Frailty: From the Kidney to the Heart
Gaetano Santulli, Fahimeh Varzideh, Imma Forzano, et al.
Hypertension (2023) Vol. 80, Iss. 9, pp. 1800-1809
Open Access | Times Cited: 39

Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial
Tae Won Yi, Brendan Smyth, Gian Luca Di Tanna, et al.
American Journal of Kidney Diseases (2023) Vol. 82, Iss. 1, pp. 84-96.e1
Open Access | Times Cited: 18

Clinical impacts of frailty on 123,172 people with diabetes mellitus considering the age of onset and drugs of choice: a nationwide population-based 10-year trajectory analysis
Shih‐Tsung Huang, Liang‐Kung Chen, Fei‐Yuan Hsiao
Age and Ageing (2023) Vol. 52, Iss. 7
Closed Access | Times Cited: 18

Sodium–glucose transporter-2 inhibitors for prevention and treatment of cardiorenal complications of type 2 diabetes
Dario Giugliano, Miriam Longo, Lorenzo Scappaticcio, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 34

Hypoglycaemic therapy in frail older people with type 2 diabetes mellitus—a choice determined by metabolic phenotype
Alan J. Sinclair, Daniel Pennells, Ahmed H. Abdelhafiz
Aging Clinical and Experimental Research (2022) Vol. 34, Iss. 9, pp. 1949-1967
Open Access | Times Cited: 28

Metabolic Impact of Frailty Changes Diabetes Trajectory
Alan J. Sinclair, Ahmed H. Abdelhafiz
Metabolites (2023) Vol. 13, Iss. 2, pp. 295-295
Open Access | Times Cited: 16

Evaluación de la enfermedad renal crónica en las personas españolas con diabetes: un estudio llevado a cabo en las consultas de medicina interna
Javier Ena, Juana Carretero Gómez, Manuel Suárez Tembra, et al.
Revista Clínica Española (2025)
Closed Access

Macrovascular Complications
Leocadio Rodrı́guez-Mañas, Rubí E. Sandoval‐Santoyo, Marta Castro, et al.
(2025), pp. 81-107
Closed Access

Prescribing trends of glucose-lowering drugs in older adults from 2010 to 2021: A population-based study of Northern Italy
Andreana Foresta, Elena Succurro, Marta Baviera, et al.
Diabetes Research and Clinical Practice (2023) Vol. 202, pp. 110742-110742
Closed Access | Times Cited: 8

The association between frailty and in-hospital mortality in critically ill patients with congestive heart failure: results from MIMIC-IV database
Dongsheng Su, Fengyun Wang, Yanhua Yang, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 3

Hypertension in frail older adults: current perspectives
Liying Li, Linjia Duan, Ying Xu, et al.
PeerJ (2024) Vol. 12, pp. e17760-e17760
Open Access | Times Cited: 3

Risk Factors and Cardiovascular Disease in the Elderly
Pablo Díez‐Villanueva, César Jiménez-Méndez, Clara Bonanad, et al.
Reviews in Cardiovascular Medicine (2022) Vol. 23, Iss. 6, pp. 188-188
Open Access | Times Cited: 12

Insulin in Frail, Older People with Type 2 Diabetes—Low Threshold for Therapy
Ahmed H. Abdelhafiz, Shail Bisht, Iva Kovačević, et al.
Diabetology (2022) Vol. 3, Iss. 2, pp. 369-383
Open Access | Times Cited: 8

The outcome of frailty in older people with diabetes as a function of glycaemic control and hypoglycaemic therapy: a review
Grace Keegan, Namita Bhardwaj, Ahmed H. Abdelhafiz
Expert Review of Endocrinology & Metabolism (2023) Vol. 18, Iss. 5, pp. 361-375
Closed Access | Times Cited: 4

Cardiovascular risk reduction in older people with type 2 diabetes mellitus-a comprehensive narrative review
Pann Ei Hnynn, S. Parker, Dima Abdelhafiz, et al.
Diabetes Research and Clinical Practice (2024) Vol. 211, pp. 111662-111662
Closed Access | Times Cited: 1

Effects of glycemic control on frailty: a multidimensional perspective
Ahmed H. Abdelhafiz
Hospital Practice (2023) Vol. 51, Iss. 3, pp. 124-134
Closed Access | Times Cited: 3

Newer anti-diabetic therapies with low hypoglycemic risk-potential advantages for frail older people
Demelza Emmerton, Ahmed H. Abdelhafiz
Hospital Practice (2021) Vol. 49, Iss. 3, pp. 164-175
Closed Access | Times Cited: 5

Page 1 - Next Page

Scroll to top